New York, NEW%20YORK4 Active Studies

Parkinsons Disease Clinical Trials in New York, NEW%20YORK

Find 4 actively recruiting parkinsons disease clinical trials in New York, NEW%20YORK. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
292
Enrolling

Recruiting Parkinsons Disease Studies in New York

RecruitingNew York, NEW%20YORKNCT05700825

Rehabilitation of Airway Protection in Parkinson's Disease

Airway protective disorders are a prevalent and progressive consequence of Parkinson's Disease (PD), and often result in aspiration pneumonia which is the leading cause of death in PD. Despite this, a...

120 participants
Teachers College, Columbia University
View Study Details
RecruitingNew York, NEW%20YORKNCT06944522

A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease

Study BRT-DA01-301 is a Phase 3 multicenter, randomized, sham surgery-controlled, double-blind study to assess efficacy and safety of bemdaneprocel in approximately 102 adults with Parkinson's Disease...

102 participants
BlueRock Therapeutics
View Study Details
RecruitingNew York, NEW%20YORKNCT06602193

Safety and Pharmacodynamic Effects of BIIB122 in Participants With LRRK2-Associated Parkinson's Disease (LRRK2-PD)

This Phase 2a, multicenter, randomized, 12-week double-blind, placebo-controlled, parallel-group study, followed by an OLE, is designed to evaluate the safety, tolerability, and pharmacodynamic effect...

50 participants
Denali Therapeutics Inc.
View Study Details
RecruitingNew York, NEW%20YORKNCT04127578

Phase 1/2a Clinical Trial of PR001 (LY3884961) in Patients With Parkinson's Disease With at Least One GBA1 Mutation (PROPEL)

Study J3Z-MC-OJAA is a Phase 1/2a, multicenter, open-label, ascending dose, first in-human study that will evaluate the safety of intracisternal LY3884961 administration in patients with moderate to s...

20 participants
Prevail Therapeutics
View Study Details

About Parkinsons Disease Clinical Trials in New York

Parkinson's disease is a progressive nervous system disorder that affects movement, causing tremors, stiffness, and difficulty with balance. It results from the loss of dopamine-producing neurons in the brain. Treatment includes medications, deep brain stimulation, and emerging therapies targeting disease modification.

There are currently 4 parkinsons disease clinical trials recruiting participants in New York, NEW%20YORK. These studies are seeking a combined 292 participants. Research is being sponsored by Teachers College, Columbia University, BlueRock Therapeutics, Denali Therapeutics Inc. and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Parkinsons Disease Clinical Trials in New York — FAQ

Are there parkinsons disease clinical trials in New York?

Yes, there are 4 parkinsons disease clinical trials currently recruiting in New York, NEW%20YORK. Browse the studies on this page to find one that fits.

How do I join a clinical trial in New York?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New York research site will contact you about next steps.

Are clinical trials in New York free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New York studies also compensate for your time and travel.

What parkinsons disease treatments are being tested?

The 4 active trials in New York are testing new therapies including novel drugs, biologics, and treatment approaches for parkinsons disease.

Data updated March 2, 2026 from ClinicalTrials.gov